Subsequently, we validated the above findings in the CRC cell line model, where the combination of sitagliptin and 5FU suppressed the migration, colony, and tumorsphere formation of DLD-1 and HCT116 cells, accompanied by the reduced DPP4/CTNNB1/CD24/SOX4 expression. Here, SOX4 is linked to colorectal carcinoma.